Minerva Neurosciences Stock News

Source: Shutterstock Short squeeze stocks are still worth keeping track of as traders look for potential gains this week! This has us turning to Fintel and its Short Squeeze Leaderboard for the latest

Source: Alextype/Shutterstock.com Traders continue to show interest in short squeeze stocks this week as they seek out likely targets to push higher. This has us checking out Fintel's Short Squeeze Le

Gainers Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) surged 95.3% to close at $0.2580 on Thursday after Ladenburg Thalmann initiated coverage on the stock with a Buy rating and announced a price target

Gainers Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) jumped 91% to $0.2530 after Ladenburg Thalmann initiated coverage on the stock with a Buy rating and announced a price target of $6.50. Cosmos Holdi

U.S. stocks traded higher this morning, with the Dow Jones gaining more than 100 points on Thursday. Following the market opening Thursday, the Dow traded up 0.38% to 33,094.64 while the NASDAQ rose 1

Gainers Minerva Neurosciences, Inc. (NASDAQ: NERV) shares gained 66.5% to close at $7.51 after Point72 Asset Management reported an 8.8% passive stake in the company. SuperCom Ltd. (NASDAQ: SPCB) jum

Penny stocks to buy or avoid? 3 for your watch list right now. The post Penny Stocks To Buy Now? 3 To Watch After NERV Stock Explodes 160% appeared first on Penny Stocks to Buy, Picks, News and Inform

Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares jumped 77% to $2.35. Bright Minds priced overnight marketed offering of 2.858 million units at $1.40 per unit. SuperCom Ltd. (NASDAQ: SPCB)

Shares of Minerva Neurosciences (NASDAQ: NERV ) are soaring higher by over 70%  following a purchase by Steve Cohen's Point72 Asset Management and the company's submission of a new drug application (

Gainers Bird Global, Inc. (NYSE: BRDS) shares rose 25.2% to $0.54 in pre-market trading. Bird secured permit extensions and expanded to new U.S. cities. Minerva Neurosciences, Inc. (NASDAQ: NERV) sha

Minerva's (NERV) stock surges after the company files an NDA-seeking FDA approval for its schizophrenia therapy.

Minerva's (NERV) stock surges after the company files an NDA-seeking FDA approval for its schizophrenia therapy.

Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares jumped 72.8% to close at $2.16 on Monday as the stock continued to see momentum despite the company last week announcing it is not aware of

Penny stocks to add to your watch list this week. The post 4 Hot Penny Stocks To Watch This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Penny stocks to add to your watch list this week. The post 4 Hot Penny Stocks To Watch This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.